End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
© ANZDATA Registry TRANSPLANT WAITING LIST CHAPTER 7.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 13: International Comparisons.
USRDS 1999 Point Prevalence Counts by Modality, Data Source, and Year, Count (1000s) Year Center Hemo Functioning Transplant PD Home Hemo Facility.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
Kidney Donors ANZDATA Annual Report 2014 Chapter 9.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
Obesity in the end stage kidney disease population
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
Prevalence (pmp) of Renal Replacement Therapy
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
UK Renal Registry 16th Annual Report
UK Renal Registry 9th Annual Report 2006
2013 Annual Report - 36th Edition
UK Renal Registry 10th Annual Report 2007
CHAPTER 5 Paediatric Renal Replacement Therapy
METHOD AND LOCATION OF DIALYSIS CHAPTER 4.
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
UK Renal Registry 13th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
2013 Annual Report - 36th Edition
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
American Journal of Kidney Diseases
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Prevalent Dialysis and Transplants Australia (at 31st December) Number of Patients
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Presentation transcript:

End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA

2012 update This short presentation provides the key data for treatment options according to ANZDATA Dec 2012 Trend data has also been included Slides also include some commentary about key changes or just interesting facts.

Prevalent Numbers Dec 2012 Increase 6.5%, transplant 10%, Sat/hosp 3%, PD & HHD 8% each

Incident PD patients have increased (mainly yr) whilst HD has decreased. Only 1 in 4 start on PD.

Incident HD (includes home) patients are trending younger with 57% under 65 years. PD and HD patients are similar ages.

Home Dialysis as a % of all dialysis Australia, QLD, ACT, Vic and SA increased their home dialysis percentage

Total 31% on home dialysis (up 4%)

High home dialysis rates but HHD decreasing. Low transplant prevalence.

PD up by 2%. Satellite/ hosp rates high

Increase in PD and transplant prevalence

Decrease in PD with increase in satellite. High transplant % overall

Increase in PD. Highest transplant %. HHD up slightly.

Increase in HHD but decrease in PD. Transplant prevalence low.

Decrease in PD but trend increase in HHD.

. ANZ Home Dialysis as a % of all dialysis

Conclusion Changes to prevalence and incidence of treatment options are slow but there are changes occuring. This is more evident in some states than others. This data was prepared by Kidney Health Australia utilising data fro the ANZDATA registry. If you would like to use any of these slides please acknowledge ANZDATA and Kidney Health Australia.